drugset / Trial / NCT05785611
A Study Evaluating the Effect of Filgotinib in Participants With Active Axial Spondyloarthritis
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is comparing 200 milligrams (mg) of filgotinib a day with a placebo to see if filgotinib helps to treat Axial Spondyloarthritis (axSpA) and is safe to use. The study will also be comparing 200 mg with 100 mg filgotinib a day to see if the lower dose also helps to treat axSpA.
Timeline
- Start
- 2023-04-05
- Primary completion
- 2024-09-04
- Completion
- 2028-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Filgotinib | Small molecule | 100 mg | Oral |
| Subject | Filgotinib | Small molecule | 200 mg | Oral |